• SMALL
  • MEDIUM
  • LARGE

News

Brazil reports significant upsurge in cases of Dengue


Brazil is reporting a significant upsurge in cases of Dengue. This mosquito borne disease is endemic in Brazil and outbreaks are frequently reported. Dengue produces a flu-like illness that can be unpleasant but mild. Occasionally, the disease can progress to Dengue Haemorrhagic Fever, a severe and often fatal form of the disease. 

Up until the end of March 2008, Brazilian health authorities have reported more than 4000 cases of dengue hemorrhagic fever, with 34 deaths. Brazil is seeing many thousand cases more of uncomplicated Dengue Fever this year as compared with last year.

The Brazilian states most affected include Amazonas, Rondonia, Sergipe, Bahia, Rio Grande do Norte, Para, and Rio de Janeiro. 

There is no vaccine available to protect against dengue. Travellers can reduce their risk of infection due to Dengue (and to other mosquito borne disease such as Yellow Fever and Malaria) by practising mosquito bite avoidance measures. Further information on Dengue Fever can be found here and ways to reduce the likelihood of being bitten by mosquitoes can be found here.

Dengue in Rio de Janeiro state, Brazil


Brazil is currently experiencing an epidemic of dengue fever, with 49 deaths in the state of Rio de Janeiro this year, according to local health officials. Around 32,000 cases of dengue have been reported in the state this year, most of them in the capital city Rio de Janeiro. Recent media articles have stated that the capital registered 1,100 cases of dengue fever between March 17 and March 18 and that 80 cases of dengue are being reported every hour.

Brazil as a whole reported almost 560,000 cases of dengue in 2007, and 158 deaths [1]. On 19 March, Brazil's Ministry of Health announced that it had established a dedicated crisis office to tackle the epidemic [2]. Paraguay and other countries in Latin America have also been experiencing large outbreaks of dengue fever in recent months. The majority of cases in the region occur between January and May, corresponding to the rainy season in most of the affected countries.

Dengue fever is a viral disease endemic in the Americas, Asia, the Pacific, the Caribbean and Africa. Humans are infected with dengue virus through bites of Aedes mosquitoes. There are four closely related but serologically distinct dengue virus serotypes, all of which have the potential to cause either classic dengue fever or the more severe form of the disease, dengue haemorrhagic fever. The main clinical symptoms of classic dengue are fever for two to seven days, severe headaches with pain behind the orbits of the eyes, severe muscle and joint pain, nausea and vomiting. Although dengue fever does not naturally occur in the continental European Union, it is frequently reported by travellers.

There is currently no vaccine to prevent dengue or dengue haemorrhagic fever. Travellers to endemic countries instead need to rely on the following preventive measures to minimize the exposure to mosquito bites:

For more information on preventing dengue and ECDC's work on this disease, please see the following links:

http://www.ecdc.europa.eu/Health_topics/Dengue_fever/Index.html

http://www.ecdc.europa.eu/Health_topics/Dengue_fever/facts.htm

http://www.ecdc.europa.eu/About_us/projects/env_zoon.html

References:

  1. Pan American Health Organization. 2007: Number of Reported Cases of Dengue & Dengue Hemorrhagic Fever (DHF), Region of the Americas (by country and subregion). Available from: http://www.ops-oms.org/English/AD/DPC/CD/dengue-cases-2007.htm
  2.  Ministro monta gabinete de crise contra dengue. Press release. 19 March 2008. Available from: http://portal.saude.gov.br/portal/aplicacoes/noticias/noticias_detalhe.cfm?co_seq_noticia=44277

News

 

Publications



Health Protection Surveillance Centre, 25-27 Middle Gardiner St, Dublin 1, Ireland. t: +353 1 8765300 f: +353 1 8561299 e:hpsc@hse.ie
© Health Protection Surveillance Centre 2011
Disclaimer and Privacy policy